Advanced search
Publication Cover
International Journal of General Medicine Volume 15, 2022 - Issue
Submit an article Journal homepage
159
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Retrospective Evaluation of Non-Invasive Assessment Based on Routine Laboratory Markers for Assessing Advanced Liver Fibrosis in Chronic Hepatitis B Patients

Zeyu Wang1 Department of Hepatobiliary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China
,
Yonghe Zhou2 Ultrasound department, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of China;3 Tianjin Research Institute of Liver Diseases, Tianjin, 300192, People’s Republic of China
,
Pengzhi Yu2 Ultrasound department, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of China;3 Tianjin Research Institute of Liver Diseases, Tianjin, 300192, People’s Republic of China
,
Yonggang Liu3 Tianjin Research Institute of Liver Diseases, Tianjin, 300192, People’s Republic of China;4 Pathology Department, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of China
,
Mei Mei5 Department of Gastroenterology, Tianjin Haihe Hospital, Tianjin, 300350, People’s Republic of China
,
Zhuo Bian2 Ultrasound department, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of China
,
Wei Shao2 Ultrasound department, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of China
,
Jinxia Lv2 Ultrasound department, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of China
,
Xin Li2 Ultrasound department, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of China
,
Wei Lu1 Department of Hepatobiliary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;3 Tianjin Research Institute of Liver Diseases, Tianjin, 300192, People’s Republic of China;6 Department of Hepatology, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Liang Xu3 Tianjin Research Institute of Liver Diseases, Tianjin, 300192, People’s Republic of China;6 Department of Hepatology, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of China
 show all
Pages 5159-5171 | Published online: 25 May 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.